Marker Therapeutics, Inc. Uncategorized Contracts & Agreements

16 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Work Order #1 for GMP Manufacturing Services between Marker Therapeutics, Inc. and Cell Ready LLC
Services Agreements
Marker Therapeutics, Inc.
Biotechnology
2024
Description of Securities Registered Under Section 12 of the Exchange Act – Marker Therapeutics, Inc.
Equity Distribution Agreements
Marker Therapeutics, Inc.
Biotechnology
2024
Board Observer and Director Nomination Agreement between Marker Therapeutics, Inc. and New Enterprise Associates, Inc.
Investor Rights Agreements
Marker Therapeutics, Inc.
Biotechnology
DE
2018
First Amendment to Placement Agency Agreement between TapImmune Inc. and Katalyst Securities LLC
Modification Agreements
Marker Therapeutics, Inc.
Biotechnology
2017
Amendment to TapImmune Inc. 2014 Omnibus Stock Ownership Plan
Modification Agreements
Marker Therapeutics, Inc.
Biotechnology
2015
Amendment to TapImmune Inc. 2014 Omnibus Stock Ownership Plan
Stock Agreements
Marker Therapeutics, Inc.
Biotechnology
2015
Second Amendment to Exclusive Engagement Letter between TapImmune Inc. and H.C. Wainwright & Co., LLC (March 9, 2015)
Modification Agreements
Marker Therapeutics, Inc.
Biotechnology
2015
Secured Loan Agreement between TapImmune Inc. and Lenders (2009)
Loan Agreements
Marker Therapeutics, Inc.
Biotechnology
2009
Sponsored Research Contract between Baylor College of Medicine and Marker Therapeutics, Inc. dated November 16, 2018
Marker Therapeutics, Inc.
Biotechnology
TX
2019
License and Assignment Agreement between Mayo Foundation for Medical Education and Research and TapImmune, Inc.
License Agreements
Marker Therapeutics, Inc.
Biotechnology
MN
2016
Amended and Restated Restructuring Agreement between TapImmune Inc. and Eastern Capital Limited (June 2, 2015)
Warrant Agreements
Marker Therapeutics, Inc.
Biotechnology
NY
2015
Restructuring Agreement Amending Series A, B, and C Warrants between TapImmune Inc. and Warrant Holder
Warrant Agreements
Marker Therapeutics, Inc.
Biotechnology
NY
2015
Finders Agreement between TapImmune, Inc. and Olympus Securities, LLC dated January 12, 2015
Marker Therapeutics, Inc.
Biotechnology
2015
Option Agreement Between Ayer Special Situations Fund I and TapImmune Inc. Dated March 2014
Marker Therapeutics, Inc.
Biotechnology
NY
2014
Technology Option Agreement between Mayo Foundation for Medical Education and Research and TapImmune, Inc.
License Agreements
Marker Therapeutics, Inc.
Biotechnology
MN
2010
TapImmune Inc. $0.02 Share Purchase Warrant Certificate (Series A)
Warrant Agreements
Marker Therapeutics, Inc.
Biotechnology
NV
2009